| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
144 |
104 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
315 |
273 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
142 |
104 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
156 |
131 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
47 |
47 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
166 |
127 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
27 |
26 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
26 |
25 |
$806.40 |
| 0072A |
|
19 |
19 |
$800.66 |
| 0011A |
|
18 |
17 |
$758.52 |
| 0012A |
|
17 |
17 |
$716.38 |
| 0071A |
|
16 |
16 |
$674.24 |
| 91301 |
|
34 |
33 |
$0.13 |
| 99072 |
|
79 |
68 |
$0.00 |
| 99001 |
|
53 |
46 |
$0.00 |